Compare Cytokinetics Inc (CYTK) vs SAP SE (SAP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs SAP SE — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while SAP SE trades at $207.11 (market cap $240.81B). The key difference: SAP SE is far larger — about 22.7× Cytokinetics Inc's market cap, and SAP SE pays a 1.4% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | SAP | |
|---|---|---|
Market Cap | $10.63B | $240.81B |
Sector | Technology | Technology |
52-Week High | $87.26 | $280.46 |
52-Week Low | $34.31 | $146.38 |
Enterprise Value | $10.74B | $239.52B |
Dividend Yield | — | 1.4% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About SAP SE
Founded in 1972 by former IBM employees, SAP provides database technology and enterprise resource planning software to enterprises around the world. Across more than 180 countries, the company serves 440,000 customers, approximately 80% of which are small to medium-size enterprises.
Read more on SAP →
